Birgit Geoerger

13.6k total citations
209 papers, 6.2k citations indexed

About

Birgit Geoerger is a scholar working on Molecular Biology, Neurology and Oncology. According to data from OpenAlex, Birgit Geoerger has authored 209 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Molecular Biology, 75 papers in Neurology and 74 papers in Oncology. Recurrent topics in Birgit Geoerger's work include Neuroblastoma Research and Treatments (74 papers), Glioma Diagnosis and Treatment (54 papers) and Sarcoma Diagnosis and Treatment (27 papers). Birgit Geoerger is often cited by papers focused on Neuroblastoma Research and Treatments (74 papers), Glioma Diagnosis and Treatment (54 papers) and Sarcoma Diagnosis and Treatment (27 papers). Birgit Geoerger collaborates with scholars based in France, United States and United Kingdom. Birgit Geoerger's co-authors include Gilles Vassal, Isabelle Aerts, Peter C. Phillips∥, Jacques Grill, Darren Hargrave, Paule Opolon, Alberto S. Pappo, François Doz, D. Harms and Xavier Paolettí and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Birgit Geoerger

201 papers receiving 6.2k citations

Peers

Countries citing papers authored by Birgit Geoerger

Since Specialization

Citations

This map shows the geographic impact of Birgit Geoerger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit Geoerger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit Geoerger more than expected).

Fields of papers citing papers by Birgit Geoerger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birgit Geoerger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit Geoerger. The network helps show where Birgit Geoerger may publish in the future.

Co-authorship network of co-authors of Birgit Geoerger

This figure shows the co-authorship network connecting the top 25 collaborators of Birgit Geoerger. A scholar is included among the top collaborators of Birgit Geoerger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgit Geoerger. Birgit Geoerger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CellsFromSpace: a fast, accurate, and reference-free tool to deconvolve and annotate spatially distributed omics data 2024 ·Bioinformatics Advances ·(unknown), Gaël Moquin‐Beaudry, (unknown), Maria Eugénia Marques Da Costa, (unknown), (unknown), Damien Drubay, (unknown), Birgit Geoerger, Jean‐Yves Scoazec, Nathalie Gaspar, Antonin Marchais	1
2	Twinning to reduce research and innovation inequalities in paediatric solid tumours across Europe 2024 ·SHILAP Revista de lepidopterología ·Jelena Rascon, (unknown), (unknown), Sabine Taschner‐Mandl, (unknown), (unknown), Stefan Rutkowski, Ulrich Schüller, Karsten Nysom, Ruta Tuckuviene, Jesper Brok, Kjeld Schmiegelow, Marry M. van den Heuvel‐Eibrink, (unknown), Riccardo Haupt, Monica Muraca, Davide Saraceno, Birgit Geoerger, (unknown), Ruth Ladenstein	0
3	Precision Medicine for Childhood Cancer: Current Limitations and Future Perspectives 2024 ·JCO Precision Oncology ·Martin G. McCabe, Birgit Geoerger, Louis Chesler, Darren Hargrave, D. Williams Parsons, Cornelis M. van Tilburg, Gudrun Schleiermacher, John A. Hickman, Sally L. George	4
4	Afatinib in paediatric patients with recurrent/refractory ErbB-dysregulated tumours: Results of a phase I/expansion trial 2023 ·European Journal of Cancer ·Birgit Geoerger, Lynley V. Marshall, Karsten Nysom, Guy Makin, Éric Bouffet, Anne Sophie Defachelles, Loredana Amoroso, Isabelle Aerts, Pierre Leblond, Paulette Barahona, (unknown), Eric Fu, Flavio Solca, Robert M. Lorence, David S. Ziegler	3
5	Enasidenib treatment in two individuals with D-2-hydroxyglutaric aciduria carrying a germline IDH2 mutation 2023 ·Nature Medicine ·Birgit Geoerger, Manuel Schiff, Virginie Penard‐Lacronique, Niklas Darín, (unknown), (unknown), Antonin Lamazière, (unknown), Clément Pontoizeau, Pablo Berlanga, Stéphane Ducassou, Katharine Yen, Michael Su, David P. Schenkein, Chris Ottolenghi, Stéphane de Botton	5
6	Sequential genomic analysis using a multisample/multiplatform approach to better define rhabdomyosarcoma progression and relapse 2023 ·npj Precision Oncology ·(unknown), Josephine K. Dermawan, (unknown), Leonard H. Wexler, Daniel Orbach, Fabio Vanoli, Gudrun Schleiermacher, Birgit Geoerger, (unknown), Delphine Guillemot, (unknown), (unknown), Olivier Delattre, Gaëlle Pierron, Cristina R. Antonescu	5
7	Phase II and biomarker study of programmed cell death protein 1 inhibitor nivolumab and metronomic cyclophosphamide in paediatric relapsed/refractory solid tumours: Arm G of AcSé-ESMART, a trial of the European Innovative Therapies for Children With Cancer Consortium 2021 ·European Journal of Cancer ·Claudia Pasqualini, (unknown), (unknown), Lydie Cassard, Nicolás André, (unknown), Jean‐Yves Scoazec, Antonin Marchais, (unknown), Lisa Boselli, Jonathan Grivel, Isabelle Aerts, Estelle Thébaud, Xavier Paolettí, Véronique Minard‐Colin, Gilles Vassal, Birgit Geoerger	36
8	Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma 2021 ·Blood ·(unknown), Carmen Mecca, Qi Wang, Chiara Ambrogio, Inês Mota, Nina Prokoph, (unknown), Cinzia Martinengo, Enrico Patrucco, Giulia C. Leonardi, (unknown), Achille Pich, Luca Mologni, Carlo Gambacorti‐Passerini, Laurence Brugières, Birgit Geoerger, Suzanne D. Turner, Claudia Voena, Taek-Chin Cheong, Roberto Chiarle	27
9	Clinical and molecular analysis of smoothened inhibitors in Sonic Hedgehog medulloblastoma 2021 ·Neuro-Oncology Advances ·(unknown), Jacob Torrejón, Dulanjalee Kariyawasam, Pablo Berlanga, Léa Guerrini‐Rousseau, Olivier Ayrault, Pascale Varlet, (unknown), Stéphanie Puget, Stéphanie Bolle, Kévin Beccaria, Thomas Blauwblomme, Laurence Brugières, Jacques Grill, Birgit Geoerger, Christelle Dufour, Samuel Abbou	12
10	Unmet needs for relapsed or refractory Wilms tumour: Mapping the molecular features, exploring organoids and designing early phase trials – A collaborative SIOP-RTSG, COG and ITCC session at the first SIOPE meeting 2020 ·European Journal of Cancer ·Jesper Brok, Annelies M. C. Mavinkurve‐Groothuis, Jarno Drost, Daniela Perotti, James I. Geller, Amy L. Walz, Birgit Geoerger, Claudia Pasqualini, Arnauld Verschuur, Angela Polanco, (unknown), Marry van den Heuvel‐Eibrink, Norbert Graf, Filippo Spreafico	19
11	In-Vitro and In-Vivo Establishment and Characterization of Bioluminescent Orthotopic Chemotherapy-Resistant Human Osteosarcoma Models in NSG Mice 2019 ·Cancers ·Maria Eugénia Marques Da Costa, Antonin Marchais, Anne Gomez‐Brouchet, Bastien Job, (unknown), Estelle Daudigeos‐Dubus, Olivia Fromigué, Conceição Santos, Birgit Geoerger, Nathalie Gaspar	11
12	The tyrosine kinase inhibitor crizotinib does not have clinically meaningful activity in heavily pre-treated patients with advanced alveolar rhabdomyosarcoma with FOXO rearrangement: European Organisation for Research and Treatment of Cancer phase 2 trial 90101 ‘CREATE’ 2018 ·European Journal of Cancer ·Patrick Schöffski, Agnieszka Woźniak, Michael Leahy, Steinar Aamdal, Piotr Rutkowski, Sebastian Bauer, Stephan Richter, Viktor Grünwald, Maria Dêbiec‐Rychter, Raf Sciot, Birgit Geoerger, Sandrine Marréaud, Sandra Collette, Axelle Nzokirantevye, Sandra J. Strauss	32
13	A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors 2017 ·Clinical Cancer Research ·Birgit Geoerger, Franck Bourdeaut, Steven G. DuBois, Matthias Fischer, James I. Geller, Nicholas G. Gottardo, Aurélien Marabelle, Andrew D.J. Pearson, Shakeel Modak, Thomas F. Cash, Giles Robinson, (unknown), Alessandro Matano, Suraj G. Bhansali, Jason R. Dobson, Sudha Parasuraman, Susan Chi	121
14	Precision medicine in pediatric oncology 2017 ·Current Opinion in Pediatrics ·Suzanne J. Forrest, Birgit Geoerger, Katherine A. Janeway	87
15	Vemurafenib in pediatric patients with BRAFV600E mutated high‐grade gliomas 2013 ·Pediatric Blood & Cancer ·Francisco Bautista, Angélo Paci, Véronique Minard‐Colin, Christelle Dufour, Jacques Grill, Ludovic Lacroix, Pascale Varlet, Dominique Valteau‐Couanet, Birgit Geoerger	105
16	Targeting the EWSR1-FLI1 Oncogene-Induced Protein Kinase PKC-β Abolishes Ewing Sarcoma Growth 2012 ·Cancer Research ·Didier Surdez, Magdalena Benetkiewicz, Virginie Perrin, Zhi‐Yan Han, Gaëlle Pierron, Stelly Ballet, François Lamoureux, Françoise Rédiní, Anne‐Valérie Decouvelaere, Estelle Daudigeos‐Dubus, Birgit Geoerger, Gonzague de Pinieux, Olivier Delattre, Franck Tirode	44
17	UPDATED RESULTS FROM A PHASE I STUDY OF LDE225, A SMOOTHENED ANTAGONIST, IN PEDIATRIC PATIENTS WITH RECURRENT MEDULLOBLASTOMA OR OTHER SOLID TUMORS 2012 ·UCL Discovery (University College London) ·Birgit Geoerger, Isabelle Aerts, María José Casanova, Julia Chisholm, Darren Hargrave, (unknown), David L. Ashley, Éric Bouffet, Tobey J. MacDonald, Angela Di Giannatale, Eunju Hurh, Jyotirmoy Dey, Stacey Kalambakas, (unknown), Mark W. Kieran	4
18	R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study 2011 ·Journal of Clinical Oncology ·Alberto S. Pappo, Shreyaskumar Patel, John Crowley, Denise K. Reinke, Klaus-Peter Kuenkele, Sant P. Chawla, Guy C. Toner, Robert G. Maki, Paul A. Meyers, Rashmi Chugh, Kristen N. Ganjoo, Scott M. Schuetze, Heribert Juergens, Michael Leahy, Birgit Geoerger, Robert S. Benjamin, Lee J. Helman, Laurence H. Baker	252
19	Preliminary Efficacy of the Anti-Insulin–Like Growth Factor Type 1 Receptor Antibody Figitumumab in Patients With Refractory Ewing Sarcoma 2011 ·Journal of Clinical Oncology ·Heribert Juergens, Najat C. Daw, Birgit Geoerger, Stefano Ferrari, Milena Villarroel, Isabelle Aerts, Jeremy Whelan, Uta Dirksen, Mary L. Hixon, Donghua Yin, Tao Wang, Stephanie Green, (unknown), Antonio Gualberto	165
20	Monocytic cells derived from human embryonic stem cells and fetal liver share common differentiation pathways and homeostatic functions 2010 ·Blood ·(unknown), Antonio Di Stefano, Birgit Geoerger, Sofiane Hamidi, Paule Opolon, Thomas Robert, (unknown), Jamel El‐Benna, Anne‐Lise Delezoide, Siham Boukour, (unknown), Éric Solary, William Vainchenker, Françoise Norol	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact